Provided by Tiger Trade Technology Pte. Ltd.

Anti-Pandemic Concept

1,867.50
-4.2683-0.23%
Number of Gainers:5
Number of Losers:14
Number of Flat:- -
PE:- -
High:1,871.60
Open:1,870.34
Low:1,853.56
Close:1,871.77
Volume:134.66M
Turnover:8.34B
Market Cap:1.52T
Float Cap:1.48T

Loading ...

AstraZeneca PLC Stock Falls Friday, Underperforms Market

Dow Jones
·
Aug 29

Top Midday Stories: Warsh Says Inflation Data 'Concerning'; Advent, Stripe Drop $50 Billion Bid to Buy PayPal

MT Newswires Live
·
Aug 28

European Equities Traded in the US as American Depositary Receipts Edge Higher in Friday Trading

MT Newswires Live
·
Aug 28

mRNA immunotherapy discontinuation a negative for BioNTech, says Morgan Stanley

TIPRANKS
·
Aug 28

Moderna Stock Falls on $2B Notes Deal: Is the Cancer Rally Still Intact?

TradingKey
·
Aug 28

BioNTech Halts Phase 2 mRNA Monotherapy Trial in Resected Colorectal Cancer After DSMB Review

TIPRANKS
·
Aug 28

BioNTech Terminates Phase 2 Trial of Autogene Cevumeran in Colorectal Cancer

MT Newswires Live
·
Aug 28

Jefferies sees neutral to negative read-through to Alnylam from AstraZeneca data

TIPRANKS
·
Aug 28

Novavax’s partners approved for Nuvaxovid formulation for vaccination season

TIPRANKS
·
Aug 28

iBio Advances IBIO-600 into Phase 1 Multiple-Ascending-Dose Trial Stage After Completing Single-Ascending-Dose Dosing

Reuters
·
Aug 28

Novavax's Partnership Strategy Continues to Deliver with Xfg-Adapted Nuvaxovid™ Approvals in the U.S., EU and Japan for 2026-2027 Vaccination Season

THOMSON REUTERS
·
Aug 28

Novavax, - Eligible for Royalties on Net Sales in U.S., EU, Japan for 2026-2027 Season

THOMSON REUTERS
·
Aug 28

Argus Research Upgrades Moderna to Buy From Hold, $180 Price Target

MT Newswires Live
·
Aug 28

Moderna Announces Pricing of Upsized $2.6 Billion Offering of Convertible Senior Notes

Reuters
·
Aug 28

Moderna Price Target Announced at $180.00/Share by Argus Research

Dow Jones
·
Aug 28

U.S. Stocks on the MOVE-Cytokinetics, Moderna, Ulta Beauty

Reuters
·
Aug 28

Success After a Century of Failures: Inside Moderna and Merck's Cancer Vaccine Breakthrough

Reuters
·
Aug 28

Moderna Prices $2.6 Billion Convertible Notes due 2032

MT Newswires Live
·
Aug 28

Moderna Rises After Upsized $2.6 Bln Convertible Bond Sale

Reuters
·
Aug 28

iBio FY26 Net Loss Widens to $33.04 Million; Revenue Drops to $100,000

Reuters
·
Aug 28